Different pharmacological approaches able to counteract STAT3 hyperactivation induce the growth arrest and apoptosis of tumor cells in vitro as well as tumor regression in vivo, validating STAT3 as an anticancer target to be exploited in drug discovery [11,12,13]. Here, STAT3 is linked to neoplasm.